Gepner et al. undertake a prospective observational study using a chest-patch sensor to monitor cardiovascular and hemodynamic vital signs following the BNT162b2 COVID-19 (Pfizer BioNTech) vaccine. Continuous and significant changes occurred in the vital signs, including in participants who did not report any reactions.
- Yftach Gepner
- Merav Mofaz
- Dan Yamin
